Martin Mackay, Ph.D.
Chairman
Rallybio Corp (RLYB)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Martin Mackay, Ph.D.
Martin Mackay, Ph.D. is recorded as Chairman at Rallybio Corp (RLYB). Rallybio Corp reported in an 8-K filed July 23, 2024 that Martin Mackay, Ph.D. resigned as Executive Chairman, effective December 31, 2024. Rallybio Corp reported in an 8-K filed June 29, 2023 that Martin Mackay, Ph.D. was appointed Executive Chairman, effective August 1, 2023.
“On July 23, 2024, Martin Mackay, Ph.D., informed the Board of Directors (the Board) of Rallybio Corporation (Rallybio) that he will resign his Executive Chairman role and his employment with Rallybio, effective December 31, 2024.”
“Dr. Mackay, who has served as Chief Executive Officer and Chairman of the Board since 2018, has been appointed to Executive Chairman, effective August 1, 2023.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-08-01–present
-
2023-08-01–2024-12-31
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Rallybio Corp
Other people whose current roles at this company are on record from its filings.
- Athena Countouriotis, M.D. CEO
- Stephen Uden CEO, COO, Board Member
- Stephen Uden, M.D. CEO, Board Member
- Jonathan I. Lieber CFO
- Scott Lipman, M.B.A. CFO
- Brian Sun, J.D. General Counsel
- Christine A. Nash Board Member
- Helen M. Boudreau Board Member
- Hui Liu Board Member
- Hui Liu, Ph.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.